Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice.

Front Endocrinol (Lausanne) · 2023 · PMC9908601 · PMID 36777358

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

The Lactobacillus belonging to the Firmicutes has an increasing trend, and the norank_f:Muribaculaceae belonging to the Bacteroidetes showed a decreasing trend, which is more evident at 22 weeks, namely the late stage of the disease.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.